This site uses cookies

×

Impinj uses cookies to improve your user experience on our website. Cookies enable you to use certain features, sharing functionality, and to tailor messages to your interests (on our site and others). They also help us understand how our site is being used. By continuing to use our site, you consent to use our cookies in accordance with our privacy policy.

Skip navigation

Impinj-Powered UHF Gen 2 RFID Solution Delivers Exceptional Results for Item Tagging of Pharmaceuticals

Impinj, Inc., a leading provider of Gen 2 radio frequency identification (RFID) chips and readers, today announced the results of a live demonstration conducted yesterday by the HealthCare Packaging division of Owens-Illinois (O-I) at the RFID Health Care Industry Adoption Summit in Washington, D.C..

Seattle, WA November 14, 2006 - Impinj, Inc., a leading provider of Gen 2 radio frequency identification (RFID) chips and readers, today announced the results of a live demonstration conducted yesterday by the HealthCare Packaging division of Owens-Illinois (O-I) at the RFID Health Care Industry Adoption Summit in Washington, D.C..

In pharmaceutical manufacturing and fill-line demonstrations, a near-field UHF Gen 2 RFID solution, comprising Impinj's Speedway™ reader and O-I's item-level embedded RFID tags powered by Impinj's Monza™ chips, achieved 100% reliability when reading and writing tags at high speed on pharmaceutical bottles. In the first demonstration, the UHF Gen 2 system programmed 96-bit EPC numbers at rates exceeding 600 tags per minute on bottles containing the four most common dose types — liquids, gel caps, solids and powder. In the second demonstration, the system developed by Impinj and O-I flawlessly read 600 tags per minute on cases containing 48 individually tagged bottles and a case-level tag.

"These results are a true breakthrough in item-level RFID implementation," said Michael Liard, Research Director, RFID & Contactless at ABI Research. "The demonstrations validate that a near-field UHF RFID solution exists and that it provides remarkable performance and reliability. The focus on RFID as part of the packaging, and not a standalone label attached to the packaging at the item-level in pharmaceuticals, is both innovative and exciting. With these solutions being made available, we can expect to see increased interest among pharmaceutical manufacturers and retailers evaluating item-level RFID."

About Impinj

Impinj (NASDAQ: PI) helps businesses and people analyze, optimize, and innovate by wirelessly connecting billions of everyday things—such as apparel, automobile parts, luggage, and shipments—to the Internet. The Impinj platform uses RAIN RFID to deliver timely data about these everyday things to business and consumer applications, enabling a boundless Internet of Things. www.impinj.com

Media Contact

Jill West
Sr. Director Global Marketing & Communications
Phone: +1 206-834-1110
[email protected]

Learn more about Impinj

Impinj News Room

Find Impinj press releases and media resources. 

Go to Impinj news room
Impinj Investor Relations

Find investor information. Impinj is publicly traded (NASDAQ: PI).

Go to investor website
Impinj Blog

Find the latest news about Impinj, our partners, RAIN RFID, and IoT.

Go to Impinj blog